 Connection
Lauren Vanderlinden to Prognosis
This is a "connection" page, showing publications Lauren Vanderlinden has written about Prognosis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.104 |
|
|
|
-
Hohsfield KR, Carry P, Slack S, Repaci CT, Vanderlinden LA, Kechris K, Rewers M, Norris JM, Johnson RK. Differences in immune cell profiles around the time of islet autoimmunity seroconversion in children with and without type 1 diabetes. BMJ Open Diabetes Res Care. 2026 May 25; 14(3).
Score: 0.032
-
Bergstrom K, Smith H, Johnson RK, Vanderlinden LA, Seifert J, Hohsfield KR, Yang IV, Slack SD, Dong F, Kechris K, Rewers M, Norris JM, Carry PM. Longitudinal changes in epigenetic age acceleration prior to type 1 diabetes onset in the Diabetes Autoimmunity Study in the Young (DAISY). BMJ Open Diabetes Res Care. 2026 Mar 10; 14(2).
Score: 0.032
-
Sottnik JL, Vanderlinden L, Joshi M, Chauca-Diaz A, Owens C, Hansel DE, Sempeck C, Ghosh D, Theodorescu D. Androgen Receptor Regulates CD44 Expression in Bladder Cancer. Cancer Res. 2021 06 01; 81(11):2833-2846.
Score: 0.022
-
Duex JE, Owens C, Chauca-Diaz A, Dancik GM, Vanderlinden LA, Ghosh D, Leivo MZ, Hansel DE, Theodorescu D. Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis. Cancer Res. 2017 09 15; 77(18):4858-4867.
Score: 0.017
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|